ArticleBMJ open2025

Safety and potential efficacy of DM199, a tissue kallikrein-1 analogue, for treating pre-eclampsia and fetal growth restriction: study protocol for a South African, hospital-based phase I/II open-label trial.

Catherine Anne Cluver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.